Insomnia: clinical experience with Zolpidem (Sanval)

The paper describes the present view of the problem of insomnia and gives a classification of sleep disorders and basic methods for their drug and non-drug therapy. Emphasis is placed on the role of the objective sleep study - polysomnography. The use of the current hypnotics belonging to a three Zs...

Full description

Bibliographic Details
Main Author: Ya. I. Levin
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2010-09-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
Online Access:https://nnp.ima-press.net/nnp/article/view/64
id doaj-60673db7de4b49a89b5b541a2e005e3c
record_format Article
spelling doaj-60673db7de4b49a89b5b541a2e005e3c2021-07-29T08:58:31ZrusIMA-PRESS LLCNevrologiâ, Nejropsihiatriâ, Psihosomatika2074-27112310-13422010-09-0123879010.14412/2074-2711-2010-10864Insomnia: clinical experience with Zolpidem (Sanval)Ya. I. Levin0I.M. Sechenov First Moscow State Medical UniversityThe paper describes the present view of the problem of insomnia and gives a classification of sleep disorders and basic methods for their drug and non-drug therapy. Emphasis is placed on the role of the objective sleep study - polysomnography. The use of the current hypnotics belonging to a three Zs group and the minimization of administration of benzodiazepines are most important in pharmacotherapy for insomnia. The results of a clinical polysomnographic study of the effect of Zolpidem (Sanval) in patients with insomnia are presented. The subjective evaluation of the beneficial effect of a 10-day course of Sanval is confirmed by the objective studies of the sleep pattern undergoing positive changes in the most important indicators, such as the process of falling asleep, the time of intrasleep awakenings, and the duration of Δ-sleep. The high safety and good tolerability of Sanval permit the latter to be assessed as an effective agent for the treatment of insomnia.https://nnp.ima-press.net/nnp/article/view/64sleepsleep disordersinsomniatreatmentsanval
collection DOAJ
language Russian
format Article
sources DOAJ
author Ya. I. Levin
spellingShingle Ya. I. Levin
Insomnia: clinical experience with Zolpidem (Sanval)
Nevrologiâ, Nejropsihiatriâ, Psihosomatika
sleep
sleep disorders
insomnia
treatment
sanval
author_facet Ya. I. Levin
author_sort Ya. I. Levin
title Insomnia: clinical experience with Zolpidem (Sanval)
title_short Insomnia: clinical experience with Zolpidem (Sanval)
title_full Insomnia: clinical experience with Zolpidem (Sanval)
title_fullStr Insomnia: clinical experience with Zolpidem (Sanval)
title_full_unstemmed Insomnia: clinical experience with Zolpidem (Sanval)
title_sort insomnia: clinical experience with zolpidem (sanval)
publisher IMA-PRESS LLC
series Nevrologiâ, Nejropsihiatriâ, Psihosomatika
issn 2074-2711
2310-1342
publishDate 2010-09-01
description The paper describes the present view of the problem of insomnia and gives a classification of sleep disorders and basic methods for their drug and non-drug therapy. Emphasis is placed on the role of the objective sleep study - polysomnography. The use of the current hypnotics belonging to a three Zs group and the minimization of administration of benzodiazepines are most important in pharmacotherapy for insomnia. The results of a clinical polysomnographic study of the effect of Zolpidem (Sanval) in patients with insomnia are presented. The subjective evaluation of the beneficial effect of a 10-day course of Sanval is confirmed by the objective studies of the sleep pattern undergoing positive changes in the most important indicators, such as the process of falling asleep, the time of intrasleep awakenings, and the duration of Δ-sleep. The high safety and good tolerability of Sanval permit the latter to be assessed as an effective agent for the treatment of insomnia.
topic sleep
sleep disorders
insomnia
treatment
sanval
url https://nnp.ima-press.net/nnp/article/view/64
work_keys_str_mv AT yailevin insomniaclinicalexperiencewithzolpidemsanval
_version_ 1721250837874868224